Vol. 31, Issue 2, 2021September 01, 2021 PDT
PATENTS AND ANTITRUST IN THE PHARMACEUTICALS INDUSTRY
PATENTS AND ANTITRUST IN THE PHARMACEUTICALS INDUSTRY
DeForest McDuff, Ph.D., Mickey Ferri, Ph.D., Noah Brennan, M.I.A.,
Articles in Vol. 31, Issue 2, 2021
Vol. 31, Issue 2, 2021
- THE CONSUMER-WELFARE STANDARD SHOULD CEASE TO BE THE NORTH STAR OF ANTITRUSTWilliam Markham
- AN ECONOMIC PERSPECTIVE ON THE USEFULNESS OF THE CONSUMER WELFARE STANDARD AS A GUIDING FRAMEWORK FOR ANTITRUST POLICYLawrence WuCraig Malam
- A LITIGATOR’S PERSPECTIVE ON THE EVOLVING ROLE OF ECONOMICS IN ANTITRUST LITIGATIONDaniel M. Wall
- JELD-WEN: OPENING THE DOOR TO PRIVATE MERGER CHALLENGES?Neely B. AginSusannah P. TorpeyDana Cook-Milligan
- THE EVOLUTION OF ANTITRUST ARBITRATIONChristopher R. Leslie
- FAIRNESS REQUIRES THE ELIMINATION OF FORCED ARBITRATIONGeoffrey H. KozenNigar A. ShaikhPamela GilbertHeidi M. SiltonRobert S. Kitchenoff
- PATENTS AND ANTITRUST IN THE PHARMACEUTICALS INDUSTRYDeForest McDuff, Ph.D.Mickey Ferri, Ph.D.Noah Brennan, M.I.A.
- TEN YEARS POST-THERASENSE: CLOSING THE GAP BETWEEN WALKER PROCESS FRAUD AND INEQUITABLE CONDUCTAnne Y. BrodyElisabeth Ponce
- “COMPETITION POLICY IN ITS BROADEST SENSE”: CAN ANTITRUST ENFORCEMENT BE A TOOL TO COMBAT SYSTEMIC RACISM?Rosa M. Morales
- ON BEING A TRANSWOMAN LAWYER…Danielle Joy Healey
DeForest McDuff, Ph.D., Mickey Ferri, Ph.D. & Noah Brennan, M.I.A., PATENTS AND ANTITRUST IN THE PHARMACEUTICALS INDUSTRY, 31 Competition Journal (2021).